BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
May 03, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Covidien sales and marketing update

Covidien launched Exalgo hydromorphone in the U.S. to manage moderate to severe pain in opioid-tolerant patients. Covidien has U.S. commercialization rights to the extended-release formulation of hydromorphone from...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >